ReShape Lifesciences, Inc. - Common Stock (RSLS)
0.7346
-0.1704 (-18.83%)
Reshape Lifesciences Inc is a biotechnology company focused on developing innovative medical technologies and solutions for weight management and obesity-related health issues
The company's primary aim is to enhance patient outcomes through its proprietary products, which include minimally invasive procedures designed to aid in weight loss and promote healthier lifestyles. By leveraging advanced engineering and clinical expertise, Reshape Lifesciences seeks to address the growing global health crisis associated with obesity and its complications, ultimately striving to empower individuals to take control of their health through effective interventions.
Frequently Asked Questions
Is ReShape Lifesciences, Inc. - Common Stock publicly traded?
Yes, ReShape Lifesciences, Inc. - Common Stock is publicly traded.
What exchange does ReShape Lifesciences, Inc. - Common Stock trade on?
ReShape Lifesciences, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for ReShape Lifesciences, Inc. - Common Stock?
The ticker symbol for ReShape Lifesciences, Inc. - Common Stock is RSLS on the Nasdaq Stock Market
What is the current price of ReShape Lifesciences, Inc. - Common Stock?
The current price of ReShape Lifesciences, Inc. - Common Stock is 0.7346
When was ReShape Lifesciences, Inc. - Common Stock last traded?
The last trade of ReShape Lifesciences, Inc. - Common Stock was at 4:00 pm EDT on March 10th, 2025
What is the market capitalization of ReShape Lifesciences, Inc. - Common Stock?
The market capitalization of ReShape Lifesciences, Inc. - Common Stock is 4.53M
How many shares of ReShape Lifesciences, Inc. - Common Stock are outstanding?
ReShape Lifesciences, Inc. - Common Stock has 6.17M shares outstanding.